Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Corvus Pharmaceuticals Inc’s current trading price is -67.60% away from its 52-week high, while its distance from the 52-week low is 149.23%. The stock’s price range during this period has varied between $1.30 and $10.00. The company, active in the Healthcare sector, saw a trading volume of around 1.38 million for the day, considerably higher average daily volume of 0.62 million observed over the last three months.
Corvus Pharmaceuticals Inc had a pretty favorable run when it comes to the market performance. Over the past year, the company’s stock reached a high of $10.00 on 11/13/24, while the lowest price during the same period was $1.30 on 04/18/24.
How Financial Performance Impacts Market Capitalization
Corvus Pharmaceuticals Inc (CRVS) has experienced a quarterly decline of -36.47% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 220.76M and boasts a workforce of 31 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 5.27, with a change in price of -5.10. Similarly, Corvus Pharmaceuticals Inc recorded 859,208 in trading volume during the last 100 days, posting a change of -61.15%.
How CRVS’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for CRVS stands at 0.03. Similarly, the long-term debt-to-equity ratio is also 0.03.
CRVS Stock Stochastic Average
As of today, the raw stochastic average of Corvus Pharmaceuticals Inc over the last 50 days is at 22.51%. This shows a declinee from the raw stochastic average of the previous 20 days, which was recorded at 31.64%. Further, the company’s Stochastic %K and %D values for the last 20 days were 24.45% and 20.26%, respectively.
CRVS Stock Price Performance Analysis
Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. This year’s metric has recorded a Price decrease of -39.44%. However, over the past six months, we’ve seen a stronger performance of -48.82%. The price of CRVS leaped by -31.36% over the last 30 days. And in the last five days, it has surged by 14.89%.
